Schulz, C. and Laack, E. and Wolff, T. and Rueckert, A. and Reck, M. and Faehling, M. and Fischer, J. R. and de Wit, M. (2018) PACIFIC: a double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC. ONCOLOGY RESEARCH AND TREATMENT, 41 (suppl4). p. 270. ISSN 2296-5270, 2296-5262
Full text not available from this repository.Item Type: | Article |
---|---|
Subjects: | 600 Technology > 610 Medical sciences Medicine |
Divisions: | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) |
Depositing User: | Petra Gürster |
Date Deposited: | 23 Jun 2020 14:04 |
Last Modified: | 23 Jun 2020 14:04 |
URI: | https://pred.uni-regensburg.de/id/eprint/15329 |
Actions (login required)
![]() |
View Item |